289 related articles for article (PubMed ID: 23007156)
21. SINE Retrotransposition: Evaluation of Alu Activity and Recovery of De Novo Inserts.
Ade C; Roy-Engel AM
Methods Mol Biol; 2016; 1400():183-201. PubMed ID: 26895055
[TBL] [Abstract][Full Text] [Related]
22. Deciphering the role of a SINE-VNTR-Alu retrotransposon polymorphism as a biomarker of Parkinson's disease progression.
Fröhlich A; Pfaff AL; Middlehurst B; Hughes LS; Bubb VJ; Quinn JP; Koks S
Sci Rep; 2024 May; 14(1):10932. PubMed ID: 38740892
[TBL] [Abstract][Full Text] [Related]
23. CRISPR Deletion of a SVA Retrotransposon Demonstrates Function as a
Price E; Gianfrancesco O; Harrison PT; Frank B; Bubb VJ; Quinn JP
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33671852
[TBL] [Abstract][Full Text] [Related]
24. SVA retrotransposons: Evolution and genetic instability.
Hancks DC; Kazazian HH
Semin Cancer Biol; 2010 Aug; 20(4):234-45. PubMed ID: 20416380
[TBL] [Abstract][Full Text] [Related]
25. Active human retrotransposons: variation and disease.
Hancks DC; Kazazian HH
Curr Opin Genet Dev; 2012 Jun; 22(3):191-203. PubMed ID: 22406018
[TBL] [Abstract][Full Text] [Related]
26. Involvement of Conserved Amino Acids in the C-Terminal Region of LINE-1 ORF2p in Retrotransposition.
Christian CM; Sokolowski M; deHaro D; Kines KJ; Belancio VP
Genetics; 2017 Mar; 205(3):1139-1149. PubMed ID: 28100588
[TBL] [Abstract][Full Text] [Related]
27. Reprogramming triggers endogenous L1 and Alu retrotransposition in human induced pluripotent stem cells.
Klawitter S; Fuchs NV; Upton KR; Muñoz-Lopez M; Shukla R; Wang J; Garcia-Cañadas M; Lopez-Ruiz C; Gerhardt DJ; Sebe A; Grabundzija I; Merkert S; Gerdes P; Pulgarin JA; Bock A; Held U; Witthuhn A; Haase A; Sarkadi B; Löwer J; Wolvetang EJ; Martin U; Ivics Z; Izsvák Z; Garcia-Perez JL; Faulkner GJ; Schumann GG
Nat Commun; 2016 Jan; 7():10286. PubMed ID: 26743714
[TBL] [Abstract][Full Text] [Related]
28. The landscape of human SVA retrotransposons.
Chu C; Lin EW; Tran A; Jin H; Ho NI; Veit A; Cortes-Ciriano I; Burns KH; Ting DT; Park PJ
Nucleic Acids Res; 2023 Nov; 51(21):11453-11465. PubMed ID: 37823611
[TBL] [Abstract][Full Text] [Related]
29. Selective inhibition of Alu retrotransposition by APOBEC3G.
Hulme AE; Bogerd HP; Cullen BR; Moran JV
Gene; 2007 Apr; 390(1-2):199-205. PubMed ID: 17079095
[TBL] [Abstract][Full Text] [Related]
30. Retrotransposable genetic elements causing neutrophil defects.
Roos D; de Boer M
Eur J Clin Invest; 2018 Nov; 48 Suppl 2():e12953. PubMed ID: 29774526
[TBL] [Abstract][Full Text] [Related]
31. A novel composite retrotransposon derived from or generated independently of the SVA (SINE/VNTR/Alu) transposon has undergone proliferation in gibbon genomes.
Hara T; Hirai Y; Baicharoen S; Hayakawa T; Hirai H; Koga A
Genes Genet Syst; 2012; 87(3):181-90. PubMed ID: 22976393
[TBL] [Abstract][Full Text] [Related]
32. Potential for genomic instability associated with retrotranspositionally-incompetent L1 loci.
Kines KJ; Sokolowski M; deHaro DL; Christian CM; Belancio VP
Nucleic Acids Res; 2014; 42(16):10488-502. PubMed ID: 25143528
[TBL] [Abstract][Full Text] [Related]
33. Effect of reverse transcriptase inhibitors on LINE-1 and Ty1 reverse transcriptase activities and on LINE-1 retrotransposition.
Dai L; Huang Q; Boeke JD
BMC Biochem; 2011 May; 12():18. PubMed ID: 21545744
[TBL] [Abstract][Full Text] [Related]
34. Retrotransposable elements and human disease.
Callinan PA; Batzer MA
Genome Dyn; 2006; 1():104-115. PubMed ID: 18724056
[TBL] [Abstract][Full Text] [Related]
35. The endonuclease domain of the LINE-1 ORF2 protein can tolerate multiple mutations.
Kines KJ; Sokolowski M; deHaro DL; Christian CM; Baddoo M; Smither ME; Belancio VP
Mob DNA; 2016; 7():8. PubMed ID: 27099633
[TBL] [Abstract][Full Text] [Related]
36. Enrichment of processed pseudogene transcripts in L1-ribonucleoprotein particles.
Mandal PK; Ewing AD; Hancks DC; Kazazian HH
Hum Mol Genet; 2013 Sep; 22(18):3730-48. PubMed ID: 23696454
[TBL] [Abstract][Full Text] [Related]
37. Methyl-CpG-binding protein 2 represses LINE-1 expression and retrotransposition but not Alu transcription.
Yu F; Zingler N; Schumann G; Strätling WH
Nucleic Acids Res; 2001 Nov; 29(21):4493-501. PubMed ID: 11691937
[TBL] [Abstract][Full Text] [Related]
38. LINE-mediated retrotransposition of marked Alu sequences.
Dewannieux M; Esnault C; Heidmann T
Nat Genet; 2003 Sep; 35(1):41-8. PubMed ID: 12897783
[TBL] [Abstract][Full Text] [Related]
39. The Zinc-Finger Antiviral Protein ZAP Inhibits LINE and Alu Retrotransposition.
Moldovan JB; Moran JV
PLoS Genet; 2015 May; 11(5):e1005121. PubMed ID: 25951186
[TBL] [Abstract][Full Text] [Related]
40. Alu retrotransposition-mediated deletion.
Callinan PA; Wang J; Herke SW; Garber RK; Liang P; Batzer MA
J Mol Biol; 2005 May; 348(4):791-800. PubMed ID: 15843013
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
